http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104024248-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2012-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e74e0d47a6a2bfa4989033e78379dd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f857c62e3f8d06b5231ad2a9c645d274
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16328a98c93ebe9fae12b63b98720016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b0005251f7dc8ce6f89d873919a7a8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51bf76b6b5a00f0dfe3dd1c4bdca92d9
publicationDate 2014-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104024248-A
titleOfInvention Serine/Threonine PAK1 Inhibitors
abstract The present invention relates to compounds of formula I, wherein A, Z, R 1a , R 1b , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 , R 10 , R a , R b and n is as defined herein, and the compound is an inhibitor of PAK1. The present application also discloses compositions and methods for treating cancer and hyperproliferative disorders.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108689901-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108689901-A
priorityDate 2011-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011060295-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006074057-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007049041-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005049033-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006123113-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0250065-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468197974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467496077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467049807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163852269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465575481

Total number of triples: 35.